In recent trading session, NeuroSense Therapeutics Ltd (NASDAQ:NRSN) saw 0.46 million shares changing hands at last check today with its beta currently measuring 1.24. Company’s recent per share price level of $1.31 trading at $0.03 or 2.34% at last check today assigns it a market valuation of $30.29M. That most recent trading price of NRSN’s stock is at a discount of -77.86% from its 52-week high price of $2.33 and is indicating a premium of 61.07% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.52 million shares which gives us an average trading volume of 239.55K if we extend that period to 3-months.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
Upright in the green today for gaining 2.34%, in the last five days NRSN remained trading in the green while hitting it’s week-highest on Thursday, 12/19/24 when the stock touched $1.31 price level, adding 0.76% to its value on the day. NeuroSense Therapeutics Ltd’s shares saw a change of 66.88% in year-to-date performance and have moved 52.33% in past 5-day. NeuroSense Therapeutics Ltd (NASDAQ:NRSN) showed a performance of 32.31% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 2.01 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NeuroSense Therapeutics Ltd (NRSN) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.06% during past 5 years.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s Major holders
ARMISTICE CAPITAL, LLC is the top institutional holder at NRSN for having 1.58 million shares of worth $1.77 million. And as of 2024-06-30, it was holding 10.2822 of the company’s outstanding shares.
The second largest institutional holder is MEITAV INVESTMENT HOUSE LTD, which was holding about 40000.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.2597 of outstanding shares, having a total worth of $44800.0.
